Comments
Loading...

Enlivex Therapeutics

ENLVNASDAQ
Logo brought to you by Benzinga Data
$1.55
0.042.65%
At Close: -
$1.59
0.042.48%
After Hours: 6:52 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$13.00
Lowest Price Target1
$6.00
Consensus Price Target1
$9.50

Enlivex Therapeutics (NASDAQ:ENLV) Stock, Analyst Ratings, Price Targets, Forecasts

Enlivex Therapeutics Ltd has a consensus price target of $9.5 based on the ratings of 2 analysts. The high is $13 issued by EF Hutton on August 27, 2024. The low is $6 issued by HC Wainwright & Co. on September 9, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., EF Hutton, and HC Wainwright & Co. on September 9, 2024, August 27, 2024, and June 11, 2024, respectively. With an average price target of $8.33 between HC Wainwright & Co., EF Hutton, and HC Wainwright & Co., there's an implied 424.60% upside for Enlivex Therapeutics Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
Jun
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
EF Hutton

1calculated from analyst ratings

Analyst Ratings for Enlivex Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Enlivex Therapeutics (ENLV) stock?

A

The latest price target for Enlivex Therapeutics (NASDAQ:ENLV) was reported by HC Wainwright & Co. on September 9, 2024. The analyst firm set a price target for $6.00 expecting ENLV to rise to within 12 months (a possible 277.71% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Enlivex Therapeutics (ENLV)?

A

The latest analyst rating for Enlivex Therapeutics (NASDAQ:ENLV) was provided by HC Wainwright & Co., and Enlivex Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Enlivex Therapeutics (ENLV)?

A

There is no last upgrade for Enlivex Therapeutics

Q

When was the last downgrade for Enlivex Therapeutics (ENLV)?

A

There is no last downgrade for Enlivex Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Enlivex Therapeutics (ENLV)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enlivex Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enlivex Therapeutics was filed on September 9, 2024 so you should expect the next rating to be made available sometime around September 9, 2025.

Q

Is the Analyst Rating Enlivex Therapeutics (ENLV) correct?

A

While ratings are subjective and will change, the latest Enlivex Therapeutics (ENLV) rating was a reiterated with a price target of $6.00 to $6.00. The current price Enlivex Therapeutics (ENLV) is trading at is $1.59, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.